Renaissance Technologies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-240,927
| Closed | -$16.8M | – | 4509 |
|
2022
Q3 | $16.8M | Sell |
240,927
-27,373
| -10% | -$1.91M | 0.02% | 760 |
|
2022
Q2 | $18M | Buy |
268,300
+174,300
| +185% | +$11.7M | 0.02% | 783 |
|
2022
Q1 | $7.73M | Buy |
+94,000
| New | +$7.73M | 0.01% | 1297 |
|
2021
Q3 | – | Sell |
-41,907
| Closed | -$6.77M | – | 3950 |
|
2021
Q2 | $6.77M | Sell |
41,907
-47,993
| -53% | -$7.75M | 0.01% | 1442 |
|
2021
Q1 | $15.4M | Sell |
89,900
-94,200
| -51% | -$16.1M | 0.02% | 926 |
|
2020
Q4 | $40.4M | Buy |
+184,100
| New | +$40.4M | 0.04% | 427 |
|
2020
Q1 | – | Sell |
-62,100
| Closed | -$8M | – | 3909 |
|
2019
Q4 | $8M | Sell |
62,100
-293,800
| -83% | -$37.9M | 0.01% | 1586 |
|
2019
Q3 | $27.7M | Sell |
355,900
-93,100
| -21% | -$7.25M | 0.02% | 783 |
|
2019
Q2 | $46.2M | Buy |
449,000
+398,700
| +793% | +$41.1M | 0.04% | 526 |
|
2019
Q1 | $3.69M | Buy |
50,300
+11,400
| +29% | +$836K | ﹤0.01% | 1999 |
|
2018
Q4 | $1.65M | Sell |
38,900
-58,300
| -60% | -$2.47M | ﹤0.01% | 2336 |
|
2018
Q3 | $4.58M | Buy |
97,200
+92,600
| +2,013% | +$4.36M | ﹤0.01% | 1862 |
|
2018
Q2 | $227K | Buy |
+4,600
| New | +$227K | ﹤0.01% | 3046 |
|
2017
Q2 | – | Sell |
-164,302
| Closed | -$854K | – | 3408 |
|
2017
Q1 | $854K | Buy |
+164,302
| New | +$854K | ﹤0.01% | 2599 |
|
2016
Q4 | – | Sell |
-106,800
| Closed | -$706K | – | 3521 |
|
2016
Q3 | $706K | Sell |
106,800
-128,920
| -55% | -$852K | ﹤0.01% | 2705 |
|
2016
Q2 | $1.29M | Buy |
+235,720
| New | +$1.29M | ﹤0.01% | 2423 |
|
2015
Q2 | – | Sell |
-23,900
| Closed | -$701K | – | 3430 |
|
2015
Q1 | $701K | Buy |
+23,900
| New | +$701K | ﹤0.01% | 2470 |
|
2014
Q2 | – | Sell |
-21,000
| Closed | -$400K | – | 3030 |
|
2014
Q1 | $400K | Buy |
+21,000
| New | +$400K | ﹤0.01% | 2427 |
|